Mats Olof Magnus Lidgard

Président chez Synphora AB

Profil

Mats Olof Magnus Lidgard is currently the Chairman at Synphora AB, Scandinavian Biopharma Holding AB, Trophea AB, and Creative Peptides Sweden AB.
He is also a Director at Aqilion AB and a Senior Partner at Lavindia AB.
In his former positions, Mr. Lidgard served as Chairman at Eurocine Vaccines AB, Airsonett AB, Unitech Pharma AB, and Jatab Care AB.
He was also a Director at Probi AB, Adenovir Pharma AB, and Redwood Pharma AB.
Additionally, he held the position of Chief Legal Officer at Active Biotech AB and SBL Vaccin AB.
Mr. Lidgard obtained his graduate degree from the University of Lund in 1980.

Postes actifs de Mats Olof Magnus Lidgard

Sociétés	Poste	Début
Synphora AB	Président	-
Creative Peptides Sweden AB	Directeur/Membre du Conseil	22/02/2011
Scandinavian Biopharma Holding AB	Président	-
Lavindia AB	Corporate Officer/Principal	-
Aqilion AB	Private Equity Investor	16/02/2016
Trophea AB	Président	-

Anciens postes connus de Mats Olof Magnus Lidgard

Sociétés	Poste	Fin
Adenovir Pharma AB	Directeur/Membre du Conseil	-
REDWOOD PHARMA AB	Directeur/Membre du Conseil	-
SBL Vaccin AB	Conseiller Juridique Général	-
░░░░░ ░░░░ ░░	░░░░░░░░░░	-
░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░	-

Formation de Mats Olof Magnus Lidgard

University of Lund

Graduate Degree